No black box warning on record for Pentetate Calcium Trisodium

As of the latest FDA labeling reviewed, Pentetate Calcium Trisodium (PENTETATE CALCIUM TRISODIUM) does not carry a black box warning. Standard warnings and precautions still apply — see the full Pentetate Calcium Trisodium medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Nebulized Ca-DTPA may be associated with exacerbation of asthma. Monitor patients for signs and symptoms of asthma exacerbation when administering Ca-DTPA by the inhalation route. ( 5.1 ) Ca-DTPA is associated with depletion of endogenous trace metals (e.g., zinc, magnesium, manganese). ( 5.2 ) Take appropriate safety measures to minimize contamination of care-takers by

No black box warning on record for Pentetate Calcium Trisodium

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Nebulized Ca-DTPA may be associated with exacerbation of asthma. Monitor patients for signs and symptoms of asthma exacerbation when administering Ca-DTPA by the inhalation route. ( 5.1 ) Ca-DTPA is associated with depletion of endogenous trace metals (e.g., zinc, magnesium, manganese). ( 5.2 ) Take appropriate safety measures to minimize contamination of care-takers by

Pentetate Calcium Trisodium Black Box Warning

No black box warning on record for Pentetate Calcium Trisodium

Other warnings & precautions

Pentetate Calcium Trisodium Black Box Warning

No black box warning on record for Pentetate Calcium Trisodium

Other warnings & precautions